Cargando…

Will cases of leprosy reaction increase with COVID-19 infection?

Detalles Bibliográficos
Autores principales:	Antunes, Douglas Eulálio, Goulart, Isabela Maria Bernardes, Goulart, Luiz Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367444/ https://www.ncbi.nlm.nih.gov/pubmed/32678816 http://dx.doi.org/10.1371/journal.pntd.0008460

Ejemplares similares

Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum
por: Antunes, Douglas Eulálio, et al.
Publicado: (2019)

Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2017)

Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2018)

Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy
por: de Oliveira, Marlice Fernandes, et al.
Publicado: (2019)

Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study
por: Antunes, Douglas Eulálio, et al.
Publicado: (2022)

Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts
por: Nahas, André Alan, et al.
Publicado: (2018)

Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy
por: Antunes, Douglas Eulálio, et al.
Publicado: (2013)

Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study
por: Tiago, Liliane Marques de Pinho, et al.
Publicado: (2021)

High-resolution ultrasonography for early diagnosis of neural impairment in seropositive leprosy household contacts
por: Luppi, Andrea De Martino, et al.
Publicado: (2023)

Early diagnosis of neural impairment in seropositive leprosy household contacts: The experience of a reference center in Brazil
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2023)

COVID-19, leprosy, and neutrophils
por: Schmitz, Veronica, et al.
Publicado: (2021)

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy
por: Goulart, Isabela Maria Bernardes, et al.
Publicado: (2022)

HSP60 mimetic peptides from Mycobacterium leprae as new antigens for immunodiagnosis of Leprosy
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2023)

Inequities towards leprosy-affected people: A challenge during COVID-19 pandemic
por: Mahato, Sharika, et al.
Publicado: (2020)

Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region
por: Fabri, Angélica da Conceição Oliveira Coelho, et al.
Publicado: (2015)

High yield of retrospective active case finding for leprosy in Comoros
por: Ortuño-Gutiérrez, Nimer, et al.
Publicado: (2022)

The Missing Millions: A Threat to the Elimination of Leprosy
por: Smith, William Cairns, et al.
Publicado: (2015)

Leprosy treatment: Can we replace opinions with research?
por: Scollard, David M.
Publicado: (2020)

Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist’s dilemma
por: Parajuli, Niraj, et al.
Publicado: (2021)

Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2020)

Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines
por: Lockwood, Diana N. J., et al.
Publicado: (2019)

qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients
por: Araujo, Sergio, et al.
Publicado: (2017)

Increased COVID-19 infection risk, COVID-19 vaccine inaccessibility, and unacceptability: Worrisome trio for patients with substance abuse disorders
por: Yasmin, Farah, et al.
Publicado: (2021)

Response to “Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines”
por: Kumar, Bhushan, et al.
Publicado: (2020)

Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal
por: Khadge, Saraswoti, et al.
Publicado: (2015)

COVID-19 and emerging viral infections: The case for interferon lambda
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2020)

Fever of Unknown Origin, Wasting Syndrome and Bone Marrow Involvement: A Leprosy Case Report
por: Santana, Marcela Araujo de Oliveira, et al.
Publicado: (2022)

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
por: Heneka, Michael T., et al.
Publicado: (2020)

An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia
por: Cavaliero, Arielle, et al.
Publicado: (2019)

Initiatives to address leprosy as a human rights issue through the mandate of UN Special Rapporteur: Achievements and challenges
por: Nanri, Takahiro
Publicado: (2022)

Considerations on immunization anxiety-related reactions in clusters
por: Palacios, Ricardo
Publicado: (2014)

Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction
por: Teles, Rosane M. B., et al.
Publicado: (2019)

Neurological Implications of COVID-19 Infections
por: Needham, Edward J., et al.
Publicado: (2020)

Diagnosis of mycobacterial infections based on acid-fast bacilli test and bacterial growth time and implications on treatment and disease outcome
por: Riello, Fabiane N., et al.
Publicado: (2016)

COVID-19 Is Infecting Our Clinical Acumen
por: Jain, A., et al.
Publicado: (2020)

COVID-19 and Cybersecurity: Finally, an Opportunity to Disrupt?
por: Ferreira, Ana, et al.
Publicado: (2021)

The COVID-19 infection: lessons from the Italian experience
por: Romagnani, Paola, et al.
Publicado: (2020)

Building international infection prevention and control capacity during COVID-19: Case studies from Ethiopia and Indonesia
por: Bednar, Hailey, et al.
Publicado: (2023)

The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses
por: Russell, James A., et al.
Publicado: (2022)

Survival of In-Hospital Cardiac Arrest in COVID-19 Infected Patients
por: Aldabagh, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ua4ap7l532d1159r90dsfnemrn